University of Texas Southwestern Medical Center (UT Southwestern)

Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. (2018) Chitnis T, Arnold DL, Banwell B, Brueck W, Ghezzi A, Giovannoni G, Greenberg B, et al. Journal article Efficacy and Safety of Seladelpar, a Selective Peroxisome Proliferator-Activated Receptor Delta Agonist, in Primary Biliary Cholangitis: 52-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 Study (2018) Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, Kremer A, et al. Conference contribution Sinonasal Tract Alveolar Rhabdomyosarcoma in Adults: A Clinicopathologic and Immunophenotypic Study of Fifty-Two Cases with Emphasis on Epithelial Immunoreactivity (2018) Thompson LDR, Jo VY, Agaimy A, Llombart-Bosch A, Morales GN, Machado I, Flucke U, et al. Journal article Mucosal addressin cell adhesion molecule 1 mediated intestinal lymphocyte homing is critical for the development of experimental autoimmune encephalomyelitis (2018) Kuhbandner K, Hammer A, Haase S, Terbrack E, Schippers A, Wagner N, Hussain RZ, et al. Conference contribution Coronary computed tomographic imaging in women: An expert consensus statement from the Society of Cardiovascular Computed Tomography (2018) Quynh A Truong , Rinehart S, Abbara S, Achenbach S, Berman DS, Bullock-Palmer R, Carrascosa P, et al. Journal article Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup (2018) Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, et al. Journal article The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells (2018) Lafita-Navarro MC, Kim M, Borenstein-Auerbach N, Venkateswaran N, Hao YH, Ray R, Brabletz T, et al. Journal article Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study (2018) Van Der Heijde D, Durez P, Schett G, Naredo E, Ostergaard M, Meszaros G, De Leonardis F, et al. Journal article